Impact of a Polymorphism in the IL-12p40 Gene on the Outcome of Kidney Transplantation

Transplantation Proceedings

Volumn 41, Issue 2, 2009, Pages 654-656

  Hoffmann, T W ^a   Halimi, J M ^a,b   Buchler M ^a,b   Velge Roussel, F ^a   Al Najjar, A ^b   Marliere, J F ^b   Lebranchu, Y ^a,b   Baron, C ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY; VALACICLOVIR;

3' UNTRANSLATED REGION; ACUTE GRAFT REJECTION; ARTICLE; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HETEROZYGOTE; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

3' UNTRANSLATED REGIONS; CADAVER; CYTOMEGALOVIRUS INFECTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-12 SUBUNIT P40; KIDNEY TRANSPLANTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 63149133298     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.12.002     Document Type: Article

References (9)

1. Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Front Biosci 4 (1999) D476
2. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133
3. Morahan G., Huang D., Ymer S.I., et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27 (2001) 218
4. Stanilova S., and Miteva L. Taq-I polymorphism in 3′UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun 6 (2005) 364
5. van Veen T., Crusius J.B., Schrijver H.M., et al. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 50 (2001) 275
6. Cargill M., Schrodi S.J., Chang M., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80 (2007) 273
7. Cooper A.M., and Khader S.A. IL-12p40: an inherently agonistic cytokine. Trends Immunol 28 (2007) 33
8. Presti R.M., Pollock J.L., Dal Canto A.J., et al. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188 (1998) 577
9. Reddehase M.J., Mutter W., Munch K., et al. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61 (1987) 3102